Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4870868
Max Phase: Preclinical
Molecular Formula: C16H19N3O4
Molecular Weight: 317.35
Molecule Type: Unknown
Associated Items:
ID: ALA4870868
Max Phase: Preclinical
Molecular Formula: C16H19N3O4
Molecular Weight: 317.35
Molecule Type: Unknown
Associated Items:
Canonical SMILES: O=C(CCCCCONC(=O)c1nccc2ccccc12)NO
Standard InChI: InChI=1S/C16H19N3O4/c20-14(18-22)8-2-1-5-11-23-19-16(21)15-13-7-4-3-6-12(13)9-10-17-15/h3-4,6-7,9-10,22H,1-2,5,8,11H2,(H,18,20)(H,19,21)
Standard InChI Key: BMUUUIGOTZRXBG-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 317.35 | Molecular Weight (Monoisotopic): 317.1376 | AlogP: 1.96 | #Rotatable Bonds: 8 |
Polar Surface Area: 100.55 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.91 | CX Basic pKa: 2.06 | CX LogP: 1.44 | CX LogD: 1.43 |
Aromatic Rings: 2 | Heavy Atoms: 23 | QED Weighted: 0.39 | Np Likeness Score: -0.53 |
1. Alves Avelar LA, Schrenk C, Sönnichsen M, Hamacher A, Hansen FK, Schliehe-Diecks J, Borkhardt A, Bhatia S, Kassack MU, Kurz T.. (2021) Synergistic induction of apoptosis in resistant head and neck carcinoma and leukemia by alkoxyamide-based histone deacetylase inhibitors., 211 [PMID:33360560] [10.1016/j.ejmech.2020.113095] |
Source(1):